Stocks · News reference
Ernexa Therapeutic To Present New Preclinical Data From Its ERNA-101 Lead Oncology Program At The Next-Generation Cancer Therapeutics Meeting, October 6–8
Flash Talk presentation at the Next-Generation Cancer Therapeutics meeting, co-hosted by Nature Conferences and The University of Texas MD Anderson Cancer Center. The meeting will take place October 6–8, 2026, on MD
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Ernexa Therapeutics To Present At Cell & Gene Meeting On The Mesa On October 6; Says ERNA-101 IND Submission On Track For 2026
Ernexa Therapeutics Says ERNA-201 Showed Reduced Disease Severity vs. Untreated Controls In Preliminary Collagen-Induced Arthritis Mouse Study; Pauses ERNA-201 Preclinical Spending To Prioritize ERNA-101 IND Submission In Q4 2026